Galmed Pharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 05/15/2023 | 1.35 M | $574.82 K | -22.53% | 80.21% |
| MORGAN STANLEY | 05/15/2023 | 204.25 K | $87.11 K | 13.01% | 12.16% |
| RAYMOND JAMES & ASSOCIATES | 04/14/2023 | 138.04 K | $58.87 K | 0.00% | 8.22% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2023 | 131.63 K | $56.00 K | -11.79% | 7.83% |
| CITADEL ADVISORS LLC | 05/15/2023 | 40.84 K | $17.42 K | 100.00% | 2.43% |
| VIRTU FINANCIAL LLC | 05/01/2023 | 31.63 K | $13.00 K | 100.00% | 1.88% |
| WESTERN WEALTH MANAGEMENT, LLC | 08/30/2023 | 29.54 K | $12.60 K | 0.00% | 1.76% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 05/11/2023 | 28.50 K | $12.00 K | 0.00% | 1.70% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 04/14/2023 | 27.90 K | $11.90 K | 0.00% | 1.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 27.18 K | $11.59 K | 0.00% | 1.62% |
| BELPOINTE ASSET MANAGEMENT LLC | 05/15/2023 | 14.05 K | $5.99 K | 0.00% | 0.84% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2023 | 13.72 K | $5.85 K | 2,186.00% | 0.82% |
| JANE STREET GROUP, LLC | 05/16/2023 | 13.19 K | $5.63 K | -51.55% | 0.79% |
| UBS GROUP AG | 05/12/2023 | 4.31 K | $1.84 K | -79.90% | 0.26% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 3.05 K | $1.30 K | 0.00% | 0.18% |
| TSFG, LLC | 04/21/2023 | 3.00 K | $1.00 K | 0.00% | 0.18% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/15/2024 | 2.50 K | $1.07 K | 0.00% | 0.15% |
| BOURGEON CAPITAL MANAGEMENT LLC | 04/17/2023 | 500 | $214 | 0.00% | 0.03% |
| ALLWORTH FINANCIAL LP | 04/18/2023 | 250 | $107 | 100.00% | 0.01% |
| ZRC WEALTH MANAGEMENT, LLC | 05/04/2023 | 100 | $43 | 100.00% | 0.01% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/15/2023 | 10 | $4 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 04/27/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
| ACCURATE WEALTH MANAGEMENT, LLC | 04/13/2023 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 11/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Galmed Pharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Galmed Pharmaceuticals Ltd.. The most heavily invested institutionals were:
Advisor Group, Inc.: 0
Delek Group, Ltd.: 24,552
Unterberg Capital LLC: 0
GLG LLC: 0
Virtu KCG Holdings LLC: 0
Edmond de Rothschild (Europe): 916
122.72% of Galmed Pharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 25.47 K shares in the last 24 months. This purchase volume represents approximately $36.93 K in transactions.